Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms?
@article{Crippa2019IsCT, title={Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms?}, author={J. Crippa and J. Hallak and A. W. Zuardi and F. Guimar{\~a}es and V. Tumas and R. D. Dos Santos}, journal={European Archives of Psychiatry and Clinical Neuroscience}, year={2019}, volume={269}, pages={121-133} }
Parkinson’s disease (PD) is a chronic neurodegenerative disorder characterized by motor symptoms such as bradykinesia, rest tremor, postural disturbances, and rigidity. PD is also characterized by non-motor symptoms such as sleep disturbances, cognitive deficits, and psychiatric disorders such as psychosis, depression, and anxiety. The pharmacological treatment for these symptoms is limited in efficacy and induce significant adverse reactions, highlighting the need for better treatment options… CONTINUE READING
13 Citations
Cannabidiol: a hope to treat non-motor symptoms of Parkinson's disease patients
- Medicine
- European Archives of Psychiatry and Clinical Neuroscience
- 2019
- PDF
Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson’s Disease and l-DOPA-Induced Dyskinesia
- Medicine
- Neurotoxicity Research
- 2019
- 7
The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease
- Medicine
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- 2020
- 2
From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?
- Frontiers in Psychiatry
- 2021
Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence.
- Medicine
- Cannabis and cannabinoid research
- 2020
- 1
Effects of self-administered cannabidiol in a patient with multiple system atrophy
- Medicine
- Clinical Autonomic Research
- 2020
Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
- Medicine
- Expert opinion on drug metabolism & toxicology
- 2020
- 6
Cannabis use and mental health: risks and benefits
- Medicine
- European Archives of Psychiatry and Clinical Neuroscience
- 2019
- 9
- PDF
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
- Medicine
- European Archives of Psychiatry and Clinical Neuroscience
- 2020
- 1
- PDF
References
SHOWING 1-10 OF 97 REFERENCES
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- Psychology, Medicine
- Journal of psychopharmacology
- 2014
- 137
- PDF
Cannabidiol for the treatment of psychosis in Parkinson’s disease
- Psychology, Medicine
- Journal of psychopharmacology
- 2009
- 206
NMDA antagonists for treating the non-motor symptoms in Parkinson’s disease
- Medicine
- Translational Psychiatry
- 2018
- 27
Cannabidiol as a potential treatment for psychosis
- Medicine
- Therapeutic advances in psychopharmacology
- 2019
- 15
- PDF
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?
- Psychology, Medicine
- Neurotherapeutics
- 2015
- 19
- PDF
Could cannabidiol be used as an alternative to antipsychotics?
- Psychology, Medicine
- Journal of psychiatric research
- 2016
- 20
- PDF
Cannabis (Medical Marijuana) Treatment for Motor and Non–Motor Symptoms of Parkinson Disease: An Open-Label Observational Study
- Medicine
- Clinical neuropharmacology
- 2014
- 103
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB1 and TRPV1 receptors
- Psychology, Medicine
- Experimental Neurology
- 2007
- 160
Cannabinoids in Parkinson's Disease
- Biology, Medicine
- Cannabis and cannabinoid research
- 2017
- 35
- Highly Influential
- PDF